# FDA Inspection 1010818 - Daniel J. DeAngelo, MD - March 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/daniel-j-deangelo-md/c0a07b81-2c6e-4820-8d90-00d1a331d5d3
Source feed: FDA_Inspections

> FDA Inspection 1010818 for Daniel J. DeAngelo, MD on March 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010818
- Company Name: Daniel J. DeAngelo, MD
- Inspection Date: 2017-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1297612 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/daniel-j-deangelo-md/fc5d6905-eb33-4621-80dc-57dad26fc730)
- [FDA Inspection 1297612 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/daniel-j-deangelo-md/05120119-5d01-455b-9f1c-3237dc1bb314)
- [FDA Inspection 1140900 - 2021-04-16](https://www.keypedia.com/records/fda_inspections/daniel-j-deangelo-md/2cf44067-49f3-4e95-a9d3-90faaadfe353)
- [FDA Inspection 585196 - 2009-05-20](https://www.keypedia.com/records/fda_inspections/daniel-j-deangelo-md/f6fd682f-7890-42c8-8a71-0da1ebefaf01)

Company: https://www.keypedia.com/companies/daniel-j-deangelo-md/9a6d0cc8-13b8-4412-b0b4-933a9ef1352c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c